Shanghai Medicilon Inc.

  Medicilon biology department has established an antibody drug development platform, and our team members have more than 10 years experience in custom antibody production. Medicilon's hybridoma R&D services can provide a variety of immunization methods (proteins, peptides, small molecules, whole cells) to meet with the client's needs. Development Process of Hybridoma Technology Platform Experimental Timeline 01 Antigen preparation (provided by the customer or Medicilon) 02 Standard immunization and serum titer testing 6-8 weeks 03 Fusion screening subclones 4-6 weeks 04 Providing antibody sequence 2 weeks Service Advantage Advanced animal facilities: AAALAC certification; Multiple Immunization methods:  Medicilon offers various antigen immunization schemes such as protein, peptide, VLP, whole cell and DNA for antigen preparation; High-throughput screening:  FACS, ELISA workstation, Biacore affinity, etc., with high screening efficiency; Comprehensive functional test...